Global Chondroitin Sulfate Market – Industry Trends and Forecast to 2030

Global Chondroitin Sulfate Market, By Product (Food Grade, Pharmaceutical Grade), Source (Bovine, Porcine, Poultry, Fish, Sharks, Crocodiles, Others), Form (Powder, Tablets, Capsules), End Use (Cosmetics and Personal Care, Pharmaceuticals and Nutraceuticals, Aqua Feed, Pet Food and Veterinary Supplements), Distribution Channel (Drug Stores and Pharmacies, e-Commerce Channels, Other Sales Channels) – Industry Trends and Forecast to 2030.

Chondroitin Sulfate Market Analysis and Size

According to the report of Centers for Disease Control and Prevention, 11.4 percent of adults in the United State have observed that their arthritis restrict their ability to do certain things. There are more people which are affected with arthritis as a result the demand for sodium chondroitin sulfate increases. Moreover, the demand for chondroitin sulfate is also expected to be enhanced by growing growing incidences of osteoarthritis and increasing demand for nutraceutical goods.

Data Bridge Market Research analyses that the chondroitin sulfate market is expected to reach USD 1.85 billion by 2030, which is USD 1.30 billion in 2022, registering a CAGR of 4.50% during the forecast period of 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Chondroitin Sulfate Market Scope and Segmentation

Market Definition

Chondroitin sulfate is a sulfated glycosaminoglycan which is composed of a chain of alternating sugars suhc as glucuronic acid and N-acetylgalactosamine. It is generally found in proteins as part of a proteoglycan. Chondroitin sulfate is an essential structural component for the cartilage formed between joints of hip, finger, knee and others. Chondroitin sulfate is commonly manufactured from animal sources, such as cow and shark cartilage. 

Global Chondroitin Sulfate Market Dynamics

Drivers

• Increasing demand of chondroitin sulfate in treating multiple diseases

Chondroitin sulfate has become extensively used dietary supplement for the treatment of the osteoarthritis. Chondroitin sulfate is also effective for acid reflux, painful bladder (interstitial cystitis), bone and joint disease (kashin-beck disease), cataracts, urinary tract infections (utis), dry eyes, muscle soreness after exercise, skin redness, heart attack  and irritation (psoriasis), overactive bladder, heart disease, high cholesterol, weak bones (osteoporosis). Therefore, increasing demand for chondroitin sulfate in treating multiple diseases will likely boost the market growth.

• Rising efforts of key market players to develop chondroitin sulfate

The rising efforts of key market players of pharmaceutical segment to develop chondroitin sulfate are expected to increase market growth. For instance, Bioiberica has launched a new brand identity for its healthcare-branded ingredients portfolio in July 2021. In this portfolio included Mobilee which is a patented CS Bioactive chondroitin sulfate and hyaluronic acid matrix ingredient. Such activities are likely to contribute to the growth of the market in the forecast period.

Opportunities

• Growth and expansion of nutraceutical sector

The nutraceutical sector is expected to grow at substantial rate during the forecast due to increasing investments in this sector by major market players to develop new and more effective dietary supplements. In the nutraceutical segment, it is normally used as a dietary supplement to treat joint discomfort and osteoarthritis. They are ingested to quieten arthritis pain and to strengthen cartilage, bones, and joints. Hence, the growth and expansion of the nutraceutical sector will likely create lucrative market growth opportunities.

Restraints/ Challenge

• Side effects associated with chondroitin sulfate

Increasing concern regarding several hazardous effects of chondroitin sulfate owing to direct inhalation such as diarrhea, heartburn, nausea, and constipation is expected to obstruct the growth of the market. The ill effects of the abnormal amounts of manganese are likely to challenge the growth of the chondroitin sulfate market during the forecast period.

This chondroitin sulfate market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the chondroitin sulfate market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

COVID-19 Impact on Global Chondroitin Sulfate Market

The outbreak of COVID-19 has positively affected the growth of the chondroitin sulfate market. All government agencies and market players of healthcare sector have increased their efforts to for the development of COVID-19 diagnostics and treatment methods around the world. For instance, according to the article published by National Library of Medicine in 2022, chondroitin sulfate (CS), a highly sulfated glycosaminoglycan (GAG) derivative, has exhibited a strong inhibitory effect against the coronavirus virus. The study indicated that chondroitin sulfate could support in the expansion of antiviral therapy for COVID-19 patients. As a result of increasing chondroitin sulfate research and development initiatives in the formation of efficient COVID-19 medicines, the market is expected to continue to grow throughout the forecast period.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Development

• In 2022, Infinitus, a Chinese herbal health products and services provider, introduced a new series of Li Mai Jian supplements with the theme of "Making Bones Stronger for Joint Health."
• In 2022, Bioiberica, a global life science company, started their partnership with ByHealth, a leading Chinese dietary supplement supplier, to develop a novel product for its market-leading joint health brand, High flex.

Global Chondroitin Sulfate Market Scope

The chondroitin sulfate market is segmented on the basis of product, source, form, end use and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Food Grade
• Pharmaceutical Grade

Source

• Bovine
• Porcine
• Poultry
• Fish
• Sharks
• Crocodiles
• Others

 Form

• Powder
• Tablets
• Capsules

End Use

• Cosmetics and Personal Care
• Pharmaceuticals and Nutraceuticals
• Aqua Feed
• Pet Food and Veterinary Supplements

 Distribution Channel

• Drug Stores and Pharmacies
• e-Commerce Channels
• Other Sales Channels

Chondroitin Sulfate Market Regional Analysis/Insights

The chondroitin sulfate market is analyzed and market size insights and trends are provided by country, product, source, form, end use and distribution channel as referenced above.

The countries covered in the chondroitin sulfate market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the chondroitin sulfate market in terms of revenue growth and market share owing to the increasing expansion of the major nutraceutical and pharmaceutical companies in developed nations such as the United States. Furthermore, the increasing product launches and policies of the government for the development of pharma sector are likely to boost the market growth in this region.

Asia-Pacific is expected to be the fastest developing region during the forecast period of 2023-2030 owing to the high prevalence of osteoarthritis in this region. Moreover, increasing consumer awareness regarding dietary supplement is further expected to boost the market growth in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Chondroitin Sulfate Market Share Analysis

The chondroitin sulfate market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to chondroitin sulfate market.

Some of the major players operating in the chondroitin sulfate market are:

• Solabia Group (France)
• SEIKAGAKU CORPORATION (Japan)
• JIAXING HENGJIE BIOPHARMACEUTICAL CO.,LTD. (China)
• Stanford Chemicals (U.S.)
• Sioux Pharm, Inc. (U.S.)
• ZPD A/S (Denmark)
• Summit Nutritionals International (U.S.)
• William Reed Ltd (U.K.)
• Yantai Ruikangda Biochemical Products Co., Ltd (China)
• Bioiberica S.A.U. (Spain)
• Sino Siam Bio technique Co., Ltd. (Thailand)
• Knowde (U.S.)
• Qingdao Wantuming Biological Products Co, Ltd. (China)